why choose us

First received: October 23, 2023

Clinical Trial: Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)

Study Status: Completed

Recruit Status: RECRUITING

Condition: HIV-1-infection

Study Type: INTERVENTIONAL


Official Title: A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF After Discontinuing Injectable CAB + RPV

Brief Summary: The goal of this clinical study is to learn how safe and effective it is to switch to an oral therapy of Bictegravir/Emtricitabine/Tenofovir (B/F/TAF) from Cabotegravir + Rilpivirine (CAB+RPV) in participants living with virologically suppressed human immunodeficiency virus type 1 (HIV-1), meaning participants with HIV RNA levels below detectable levels.The primary objective of this study is to assess the safety of switching to B/F/TAF in virologically suppressed participants…

Read more